TY  - GEN
AU  - Roulot,Dominique
AU  - Thibault,Vincent
AU  - Laforest,Claire
AU  - Fontaine,Hélène
AU  - Bronowicki,Jean-Pierre
AU  - Asselah,Tarik
AU  - Bourlière,Marc
AU  - Canva,Valérie
AU  - Leroy,Vincent
AU  - Loustaud-Ratti,Véronique
AU  - Ouzan,Denis
AU  - Zoulim,Fabien
AU  - Schischmanoff,Olivier
AU  - Rousseau,Chloé
AU  - Renault,Alain
AU  - Petrov-Sanchez,Ventzislava
AU  - Diallo,Alpha
AU  - Bellissant,Eric
AU  - Serfaty,Lawrence
TI  - Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study
SN  - 1473-5687
PY  - 2018///0917
KW  - Adult
KW  - Antiviral Agents
KW  - adverse effects
KW  - Carbamates
KW  - Drug Therapy, Combination
KW  - Female
KW  - Genotype
KW  - Hepacivirus
KW  - classification
KW  - Hepatitis C, Chronic
KW  - complications
KW  - Humans
KW  - Imidazoles
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - Isoquinolines
KW  - Liver Cirrhosis
KW  - virology
KW  - Male
KW  - Middle Aged
KW  - Pilot Projects
KW  - Pyrrolidines
KW  - RNA, Viral
KW  - blood
KW  - Recombinant Proteins
KW  - Ribavirin
KW  - Sulfonamides
KW  - Sustained Virologic Response
KW  - Treatment Failure
KW  - Treatment Outcome
KW  - Valine
KW  - analogs & derivatives
KW  - Viral Load
KW  - drug effects
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/MEG.0000000000001035
ER  -